The purpose of this review is to highlight the current progress, controversies, and challenges in the development of protein, gene, and cell-based approaches for clinical therapeutic angiogenesis.
Costs were shown to be lower than those of other methods which require specific equipment and high-cost disposables, while safety and traceability can be increased.
